Antiangiogenic Agents Are Effective Inhibitors of Endometriosis
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study investigated the efficacy of antiangiogenic agents in inhibiting endometriosis, finding that they significantly reduced lesion growth and vascularization in an animal model.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Hull, M. Louise; Carnock-Jones, D. Stephen; Chan, Clement L. K.; Bruner-Tran, Kaylon L.; Osteen, Kevin G.; Tom, Brian D. M.; Fan, Tai-Ping D.; Smith, Stephen K.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets 2018
- Endometriosis: harmful survival of an ectopic tissue 2006
- A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model 2014
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
Cited by (4)
- Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets 2018
- A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model 2014
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
- Endometriosis: harmful survival of an ectopic tissue 2006
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK